Evidence map›Paper›PMID 17708417›Full record

ReviewGene expression2007

Guarding the blood-brain barrier: a role for estrogen in the etiology of neurodegenerative disease.

Farida Sohrabji

Open access · hybridAbstract readReview
In one paragraph

Review in Gene expression, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. A New Hypothesis for Alzheimer's Disease: The Lipid Invasion Model.Journal of Alzheimer's disease reports · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Farida SohrabjiDepartment of Neuroscience and Experimental Therapeutics, Texas A&M Health Science Center College of Medicine, College Station, TX 77843, USA. f-sohrabji@tamu.edu
Texas A&M Health Science Center · US

Funding

Impact of Endocrine Aging on Brain and Immune ResponsesR01AG027684 · NIA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SOHRABJI, FARIDA · 2006 to 2010
$1.0M
Mechanisms and Neural Consequences of Estrogen ActionR01AG019515 · NIA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SOHRABJI, FARIDA · 2002 to 2005
$979k
Impact on Reproductive Aging on Neural-Immune ResponsesR01AG028303 · NIA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SOHRABJI, FARIDA · 2006 to 2009
$684k
NIA NIH HHS AG019515NIA NIH HHS AG027684NIA NIH HHS AG028303NIA NIH HHS R01 AG019515NIA NIH HHS R01 AG027684NIA NIH HHS R01 AG028303
6 · The paper itself

Abstract

Although the effect of estrogen replacement therapy on the incidence of the neurodegenerative disease such as Alzheimer's disease is controversial, experimental studies indicate that estrogen replacement to young adult animals is neuroprotective and that perimenopausal estrogen replacement is associated with a decreased incidence of Alzheimer's disease. Estrogen affects a wide variety of cellular processes that can protect neuronal health. This article considers the disruption of the blood-brain barrier in Alzheimer's disease and forwards the hypothesis that estrogen may preserve neural health by maintaining the integrity of the blood-brain barrier.

Indexed as

Alzheimer DiseaseAnimalsBlood-Brain BarrierEstrogensHumansInflammationNeurodegenerative DiseasesNeuroprotective AgentsEstrogensNeuroprotective Agents

Identifiers

PMID17708417
PMCPMC6032455
OpenAlexW2001639866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.